Faes Farma, S.A. (BME:FAE)
Spain
· Delayed Price · Currency is EUR 4.790
+0.005 (0.10%)
Apr 28, 2026, 5:35 PM CET
Faes Farma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 610.46 | 493.65 | 451.17 | 438.75 | 398.56 | Upgrade
|
| Other Revenue | 16.52 | 16.39 | 21.93 | 22.97 | 30.08 | Upgrade
|
| Revenue | 626.99 | 510.04 | 473.09 | 461.72 | 428.64 | Upgrade
|
| Revenue Growth (YoY) | 22.93% | 7.81% | 2.46% | 7.72% | 4.17% | Upgrade
|
| Cost of Revenue | 227.01 | 174.04 | 160.78 | 162.56 | 150.96 | Upgrade
|
| Gross Profit | 399.98 | 336 | 312.31 | 299.16 | 277.68 | Upgrade
|
| Selling, General & Admin | 170.29 | 132.55 | 121.66 | 115.89 | 86.78 | Upgrade
|
| Amortization of Goodwill & Intangibles | 29.03 | 20.32 | 19.4 | 19.27 | 17.26 | Upgrade
|
| Other Operating Expenses | 111.83 | 74.6 | 68.42 | 62.08 | 76.53 | Upgrade
|
| Operating Expenses | 311.15 | 227.47 | 209.47 | 197.23 | 180.57 | Upgrade
|
| Operating Income | 88.82 | 108.53 | 102.84 | 101.92 | 97.11 | Upgrade
|
| Interest Expense | -4.6 | - | - | -0.26 | -0.22 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.27 | -0.77 | -0.66 | -0.05 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.02 | 1.26 | 0.7 | 0.25 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | 84.98 | 109.02 | 102.88 | 101.86 | 96.82 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -0.3 | Upgrade
|
| Asset Writedown | 0.44 | -1.45 | -0.03 | -0.44 | -3.56 | Upgrade
|
| Pretax Income | 85.41 | 107.58 | 102.85 | 101.42 | 92.97 | Upgrade
|
| Income Tax Expense | 5.75 | -3.54 | 11.16 | 11.97 | 10.52 | Upgrade
|
| Earnings From Continuing Operations | 79.66 | 111.11 | 91.69 | 89.45 | 82.45 | Upgrade
|
| Minority Interest in Earnings | -0.03 | 0.25 | 0.21 | 0.05 | -0.06 | Upgrade
|
| Net Income | 79.63 | 111.36 | 91.9 | 89.5 | 82.39 | Upgrade
|
| Net Income to Common | 79.63 | 111.36 | 91.9 | 89.5 | 82.39 | Upgrade
|
| Net Income Growth | -28.49% | 21.17% | 2.69% | 8.63% | 13.56% | Upgrade
|
| Shares Outstanding (Basic) | 311 | 311 | 310 | 306 | 291 | Upgrade
|
| Shares Outstanding (Diluted) | 313 | 312 | 311 | 306 | 305 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.56% | 1.57% | 0.36% | 4.38% | Upgrade
|
| EPS (Basic) | 0.26 | 0.36 | 0.30 | 0.29 | 0.28 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.36 | 0.30 | 0.29 | 0.27 | Upgrade
|
| EPS Growth | -28.65% | 20.27% | 1.09% | 8.45% | 8.87% | Upgrade
|
| Free Cash Flow | 62.39 | 81.65 | 5.21 | 31.83 | 28.16 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.26 | 0.02 | 0.10 | 0.09 | Upgrade
|
| Dividend Per Share | - | 0.179 | 0.155 | 0.155 | 0.206 | Upgrade
|
| Dividend Growth | - | 15.48% | - | -24.76% | 4.57% | Upgrade
|
| Gross Margin | 63.79% | 65.88% | 66.02% | 64.79% | 64.78% | Upgrade
|
| Operating Margin | 14.17% | 21.28% | 21.74% | 22.07% | 22.66% | Upgrade
|
| Profit Margin | 12.70% | 21.83% | 19.43% | 19.38% | 19.22% | Upgrade
|
| Free Cash Flow Margin | 9.95% | 16.01% | 1.10% | 6.89% | 6.57% | Upgrade
|
| EBITDA | 112.16 | 124.57 | 118.53 | 117.97 | 111.24 | Upgrade
|
| EBITDA Margin | 17.89% | 24.42% | 25.05% | 25.55% | 25.95% | Upgrade
|
| D&A For EBITDA | 23.33 | 16.04 | 15.69 | 16.05 | 14.13 | Upgrade
|
| EBIT | 88.82 | 108.53 | 102.84 | 101.92 | 97.11 | Upgrade
|
| EBIT Margin | 14.17% | 21.28% | 21.74% | 22.07% | 22.66% | Upgrade
|
| Effective Tax Rate | 6.73% | - | 10.85% | 11.80% | 11.32% | Upgrade
|
| Advertising Expenses | 29.99 | 26.53 | 24.13 | 23.58 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.